Awang, Yaizah S.

HRN: 28-85-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
CEFUROXIME 750MG (VIAL)
04/12/2026
04/19/2026
IV
700mg
Q8hours
PCAP-B
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: